2m 2m 2m 2m 2m 2m 2m
ROCKET PHARMACTC (RCKT)
NASDAQ
$2.28+$0.08 (+3.64%)
Price as of Oct 22, 2026 7:30 PM EDT- $241.5MMarket Cap
- -42.11%1-Year Change
- BiotechnologyIndustry
ROCKET PHARMACTC (RCKT)
$2.28+$0.08 (+3.64%)
RCKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.20 | ||
Change | -$0.14 (-5.98%) | ||
Open | $2.34 | ||
High | $2.38 | ||
Low | $2.17 | ||
Previous Close | $2.34 | ||
Volume | 2,023,724 | ||
30-Day Average Volume | 2,294,992 | ||
1-Week Change | -0.45% | ||
1-Month Change | -32.72% | ||
1-Year Change | -42.11% | ||
3-Year Change | -87.18% | ||
5-Year Change | -92.41% | ||
Fundamentals | |||
Shares Outstanding | 109.8M | ||
Total Assets | $423.1M | ||
Market Cap | $241.5M | ||
Enterprise Value | $17.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $123.2M | ||
Free Cash Flow | -$39.6M | ||
EBIT | $132.3M | ||
EBITDA | $133.9M | ||
Net Working Capital | $258.2M | ||
EPS | $1.08 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue